Evaluation of HPV E6/E7 mRNA in predicting recurrence after Leep in cervical intraepithelial neoplasia: A study of negative findings
PLOS One · 16.10.2026 · 21 (10) · e0360914
DOI: 10.1371/journal.pone.0360914 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, erschienen am 16.10.2026. Verfasst von Yingmei Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology Department, The First People's Hospital of Nanning, Nanning, Guangxi Zhuang Autonomous Region, China. Hauptthemen laut MEDLINE: Uterine Cervical Dysplasia, RNA, Messenger, Neoplasm Recurrence, Local, Oncogene Proteins, Viral. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangxi Zhuang Autonomous Region Health Commission Self-Funded Research Project, Guangxi Zhuang Autonomous Region Health Department.
Abstract (Originalsprache)
Cervical intraepithelial neoplasia (CIN) is a precursor to cervical cancer, and early detection of residual or recurrent disease is therefore critical for effective management. This study evaluated whether HPV E6/E7 mRNA status predicts recurrence in patients with CIN who underwent loop electrosurgical excision procedure (LEEP). People’s Hospital of Nanning between January 2019 and July 2022 were included. Patients who underwent LEEP for high-grade cervical lesions at the First Follow-up commenced 4–6 months after LEEP and continued for 24 months; abnormal findings during this period prompted referral for colposcopy or cervical biopsy. Of the 91 patients, 3 (3.30%) experienced recurrence within 24 months. Recurrence rates were similar between patients with preoperative E6/E7 mRNA positivity (3.23%) and negativity (3.45%) (p = 0.956), and between postoperative E6/E7 mRNA status groups (5.26% in the negative group vs. 0% in the positive group; p = 0.814). Although 66.7% of patients shifted from positive to negative E6/E7 mRNA status after LEEP (p < 0.001), this change was not associated with recurrence risk. Preoperative E6/E7 mRNA yielded a sensitivity of 66.67% and specificity of 31.82%, whereas postoperative E6/E7 mRNA showed a sensitivity of 0% and specificity of 97.30%. In conclusion, E6/E7 mRNA status before and after LEEP did not predict recurrence in patients with CIN. Despite a significant reduction in E6/E7 mRNA positivity after surgery, its low sensitivity underscores the need for more effective biomarkers in follow-up care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gynecology Department, The First People's Hospital of Nanning, Nanning, Guangxi Zhuang Autonomous Region, China.
- Pathology Department, The First People's Hospital of Nanning, Nanning, Guangxi Zhuang Autonomous Region, China.
- Gynecology Department, The Reproductive Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region, China.
ORCID-Profile: Baoli Xie
Förderung
- Guangxi Zhuang Autonomous Region Health Commission Self-Funded Research Project
- Guangxi Zhuang Autonomous Region Health Department
Zitieren
APA
Huang, Y., Huang, J., Jiang, H., Wei, Y., Lin, Z., & Xie, B. (2026). Evaluation of HPV E6/E7 mRNA in predicting recurrence after Leep in cervical intraepithelial neoplasia: A study of negative findings. PLOS One. https://doi.org/10.1371/journal.pone.0360914
Vancouver
Huang Y, Huang J, Jiang H, Wei Y, Lin Z, Xie B. Evaluation of HPV E6/E7 mRNA in predicting recurrence after Leep in cervical intraepithelial neoplasia: A study of negative findings. PLOS One. 2026. doi:10.1371/journal.pone.0360914
BibTeX
@article{Huang2026,
author = {Huang, Yingmei and Huang, Jianyong and Jiang, Hongmian and Wei, Yumei and Lin, Zhong and Xie, Baoli},
title = {Evaluation of HPV E6/E7 mRNA in predicting recurrence after Leep in cervical intraepithelial neoplasia: A study of negative findings},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0360914}
}
EUVIMED